Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Ivermectin
nsp16
Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/30/2022
Baicalin
nsp16
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021
Irbesartan
nsp16
Potential treatment - theoretical effect Used to treat other disease Antiviral Mar/18/2021
Alvimopan
nsp16
Potential treatment - theoretical effect Used to treat other disease Antiviral Mar/18/2021
Darifenacin
nsp16
Potential treatment - theoretical effect Used to treat other disease Antiviral Mar/18/2021
Nebivolol
nsp16
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/18/2021
Bictegravir
nsp16
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/18/2021
Daidzin
nsp16
Potential treatment - theoretical effect Natural product Antiviral Mar/11/2021
6-beta-D-Glucopyranosyl-4',5-dihydroxy-7-methoxyflavone
nsp16
Potential treatment - theoretical effect Natural product Antiviral Mar/08/2021
Cynaroside
nsp16
Potential treatment - theoretical effect Natural product Antiviral Feb/16/2021
Amentoflavone
nsp16
Potential treatment - theoretical effect Natural product Antiviral Feb/16/2021
4'-Acetamido-4-dimethylaminochalcone
nsp16
Potential treatment - theoretical effect Experimental Antiviral Dec/26/2020
N-(4-[(2E)-3-(4-ethoxyphenyl)-1-(phenyl)prop-2-en-1-one]) acetamide
nsp16
Potential treatment - theoretical effect Experimental Antiviral Dec/26/2020
N-{4-[(2E)-3-(4-Methoxyphenyl)prop-2-enoyl]phenyl}acetamide
nsp16
Potential treatment - theoretical effect Experimental Antiviral Dec/26/2020
N-[4-[(E)-3-(4-Fluorophenyl)prop-2-enoyl]phenyl]acetamide
nsp16
Potential treatment - theoretical effect Experimental Antiviral Dec/26/2020
4'-Acetamidochalcone
nsp16
Potential treatment - theoretical effect Experimental Antiviral Dec/26/2020
Amphotericin B
nsp16
Potential treatment - theoretical effect Used to treat other disease Antiviral Nov/10/2020
Chlortetracycline
nsp16
Potential treatment - theoretical effect Used to treat other disease Antiviral Nov/10/2020
Ivermectin B1b
nsp16
Potential treatment - theoretical effect Used to treat other disease Antiviral Nov/10/2020
Posaconazole
nsp16
Potential treatment - theoretical effect Used to treat other disease Antiviral Nov/10/2020